Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Recombinant Human GFAP Protein (6×His Tag) (AC1157)
Cat.#: ACPP-1157
Specifications
Despition Recombinant Human GFAP Protein (6×His Tag) for SDS-PAGE SIZE 50 µg Source Recombinant Protein Length Fragment Expression System HEK293 cells Protein Species Human Sequence 6×His Tag + GFAP (Ser68-Ile377) Molecular Weight 37.2 kDa without signal peptide Purity > 85% by SDS-PAGE and Coomassie blue staining. Form Lyophilized Tag N-terminal 6×His Tag Applications SDS-PAGE Storage Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1155 Recombinant Human PCDH18 Protein (6×His Tag) (AC1155) 50 µg inquiry ACPP-1417 Human STMN3 Protein (AC1417) 2 µg inquiry ACPP-1723 Human FGF 1 Protein, Sf9 (AC1723) 2 µg inquiry ACPP-1796 Human GAP43 Protein (AC1796) 2 µg inquiry ACPP-1359 iNOS Blocking Peptide (AC1359) 250 µg inquiry ACPP-1054 Recombinant Human Neuroglycan C Protein (6×His Tag) (AC1054) 50 µg inquiry ACPP-1647 Human TUBB3 Protein (AC1647) 2 µg inquiry ACPP-1034 Recombinant Human NG2 Protein (6×His Tag) (AC1034) 50 µg inquiry ACPP-1695 Human LGALS9 Protein (AC1695) 2 µg inquiry ACPP-1237 CRMP1 Blocking Peptide (AC1237) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket